FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200326640> ?p ?o ?g. }

• W4200326640 abstract "The Immunoscore predicts prognosis in patients with colorectal cancer (CRC). However, a few studies have incorporated the Immunoscore into the construction of comprehensive prognostic models in CRC, especially stage II CRC. We aimed to construct and validate multidimensional models integrating clinicopathological characteristics and the Immunoscore to predict the prognosis of patients with stage II-III CRC.Patients (n = 254) diagnosed with stage II-III CRC from 2009 to 2016 were used to generate Cox models for predicting disease-free survival (DFS) and overall survival (OS). The variables included basic clinical indicators, blood inflammatory markers, preoperative tumor biomarkers, mismatch repair status, and the Immunoscore (CD3+ and CD8+ T-cell densities). Univariate and multivariate Cox proportional regressions were used to construct the prognostic models for DFS and OS. We validated the predictive accuracy and ability of the prognostic models in our cohort of 254 patients.We constructed two predictive prognostic models with C-index values of 0.6941 for DFS and 0.7138 for OS in patients with stage II-III CRC. The Immunoscore was the most informative predictor of DFS (11.92%), followed by pN stage, carcinoembryonic antigen (CEA), and vascular infiltration. For OS, the Immunoscore was the most informative predictor (8.59%), followed by pN stage, age, CA125, and CEA. Based on the prognostic models, nomograms were developed to predict the 3- and 5-year DFS and OS rates. Patients were divided into three risk groups (low, intermediate, and high) according to the risk scores obtained from the nomogram, and significant differences were observed in the recurrence and survival of the different risk groups (p < 0.0001). Calibration curve and time-dependent receiver operating characteristic (ROC) analysis showed good accuracy of our models. Furthermore, the decision curve analysis indicated that our nomograms had better net benefit than pathological TNM (pTNM) stage within a wide threshold probability. Especially, we developed a website based on our prognostic models to predict the risks of recurrence and death of patients with stage II-III CRC.Multidimensional models including the clinicopathological characteristics and the Immunoscore were constructed and validated, with good accuracy and convenience, to evaluate the risks of recurrence and death of stage II-III CRC patients." @default.
• W4200326640 created "2021-12-31" @default.
• W4200326640 creator A5002228713 @default.
• W4200326640 creator A5024665341 @default.
• W4200326640 creator A5033203853 @default.
• W4200326640 creator A5034152102 @default.
• W4200326640 creator A5047458448 @default.
• W4200326640 creator A5054785361 @default.
• W4200326640 creator A5058164746 @default.
• W4200326640 creator A5060185042 @default.
• W4200326640 creator A5071494012 @default.
• W4200326640 date "2021-12-03" @default.
• W4200326640 modified "2023-09-28" @default.
• W4200326640 title "Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study" @default.
• W4200326640 cites W1799482054 @default.
• W4200326640 cites W1934094702 @default.
• W4200326640 cites W1969722577 @default.
• W4200326640 cites W1976443390 @default.
• W4200326640 cites W2014229457 @default.
• W4200326640 cites W2045030989 @default.
• W4200326640 cites W2119107631 @default.
• W4200326640 cites W2138162444 @default.
• W4200326640 cites W2152032358 @default.
• W4200326640 cites W2155492044 @default.
• W4200326640 cites W2170137783 @default.
• W4200326640 cites W2239414584 @default.
• W4200326640 cites W2543412381 @default.
• W4200326640 cites W2561114892 @default.
• W4200326640 cites W2778787212 @default.
• W4200326640 cites W2795004907 @default.
• W4200326640 cites W2797024694 @default.
• W4200326640 cites W2802206159 @default.
• W4200326640 cites W2805908801 @default.
• W4200326640 cites W2949831066 @default.
• W4200326640 cites W2952481429 @default.
• W4200326640 cites W2969220132 @default.
• W4200326640 cites W2989624957 @default.
• W4200326640 cites W3013528572 @default.
• W4200326640 cites W3015200356 @default.
• W4200326640 cites W3083966623 @default.
• W4200326640 cites W3128646645 @default.
• W4200326640 cites W3134887329 @default.
• W4200326640 cites W4244315786 @default.
• W4200326640 doi "https://doi.org/10.3389/fonc.2021.776997" @default.
• W4200326640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34926285" @default.
• W4200326640 hasPublicationYear "2021" @default.
• W4200326640 type Work @default.
• W4200326640 citedByCount "3" @default.
• W4200326640 countsByYear W42003266402022 @default.
• W4200326640 countsByYear W42003266402023 @default.
• W4200326640 crossrefType "journal-article" @default.
• W4200326640 hasAuthorship W4200326640A5002228713 @default.
• W4200326640 hasAuthorship W4200326640A5024665341 @default.
• W4200326640 hasAuthorship W4200326640A5033203853 @default.
• W4200326640 hasAuthorship W4200326640A5034152102 @default.
• W4200326640 hasAuthorship W4200326640A5047458448 @default.
• W4200326640 hasAuthorship W4200326640A5054785361 @default.
• W4200326640 hasAuthorship W4200326640A5058164746 @default.
• W4200326640 hasAuthorship W4200326640A5060185042 @default.
• W4200326640 hasAuthorship W4200326640A5071494012 @default.
• W4200326640 hasBestOaLocation W42003266403 @default.
• W4200326640 hasConcept C105795698 @default.
• W4200326640 hasConcept C121608353 @default.
• W4200326640 hasConcept C126322002 @default.
• W4200326640 hasConcept C143998085 @default.
• W4200326640 hasConcept C144301174 @default.
• W4200326640 hasConcept C146357865 @default.
• W4200326640 hasConcept C151730666 @default.
• W4200326640 hasConcept C152043487 @default.
• W4200326640 hasConcept C161584116 @default.
• W4200326640 hasConcept C199163554 @default.
• W4200326640 hasConcept C2777387746 @default.
• W4200326640 hasConcept C2780091936 @default.
• W4200326640 hasConcept C3019894029 @default.
• W4200326640 hasConcept C33923547 @default.
• W4200326640 hasConcept C34626388 @default.
• W4200326640 hasConcept C38180746 @default.
• W4200326640 hasConcept C38652104 @default.
• W4200326640 hasConcept C41008148 @default.
• W4200326640 hasConcept C50382708 @default.
• W4200326640 hasConcept C526805850 @default.
• W4200326640 hasConcept C71924100 @default.
• W4200326640 hasConcept C86803240 @default.
• W4200326640 hasConceptScore W4200326640C105795698 @default.
• W4200326640 hasConceptScore W4200326640C121608353 @default.
• W4200326640 hasConceptScore W4200326640C126322002 @default.
• W4200326640 hasConceptScore W4200326640C143998085 @default.
• W4200326640 hasConceptScore W4200326640C144301174 @default.
• W4200326640 hasConceptScore W4200326640C146357865 @default.
• W4200326640 hasConceptScore W4200326640C151730666 @default.
• W4200326640 hasConceptScore W4200326640C152043487 @default.
• W4200326640 hasConceptScore W4200326640C161584116 @default.
• W4200326640 hasConceptScore W4200326640C199163554 @default.
• W4200326640 hasConceptScore W4200326640C2777387746 @default.
• W4200326640 hasConceptScore W4200326640C2780091936 @default.
• W4200326640 hasConceptScore W4200326640C3019894029 @default.
• W4200326640 hasConceptScore W4200326640C33923547 @default.
• W4200326640 hasConceptScore W4200326640C34626388 @default.
• W4200326640 hasConceptScore W4200326640C38180746 @default.
• W4200326640 hasConceptScore W4200326640C38652104 @default.

• next